MIX14 Antibody

Overview of MMP14

MMP14 is a membrane-bound zinc-dependent endopeptidase belonging to the matrix metalloproteinase family. It plays critical roles in extracellular matrix (ECM) remodeling, cell migration, and immune regulation .

Structure and Function of MMP14 Antibodies

MMP14 antibodies are designed to target specific epitopes for research and therapeutic applications.

Tumor Microenvironment Modulation

MMP14 regulates immune cell infiltration in cancers like intrahepatic cholangiocarcinoma (ICC):

• Immune Correlations:

  • Positive: M0 macrophages (r = 0.40), activated dendritic cells (r = 0.32) .

  • Negative: Monocytes (r = -0.32), M1 macrophages (r = -0.28) .

• Therapeutic Potential: Targeting MMP14 disrupts tumor-stroma interactions and enhances immunotherapy efficacy .

Diagnostic and Prognostic Utility

• Overexpression in endometrial, breast, and lung cancers correlates with poor prognosis .

• IHC Staining: Strong stromal positivity in human endometrial carcinoma (ab51074 at 1/100 dilution) .

Antibody Therapeutics

• mAb114 Analogy: While mAb114 targets Ebola virus glycoprotein, MMP14 antibodies share similar engineering principles (e.g., humanized design, linear pharmacokinetics) .

• Half-Life: ~24 days in serum, enabling sustained activity .

Available Products

Challenges and Future Directions

• Specificity Issues: Cross-reactivity with other MMPs necessitates rigorous validation (e.g., knockout controls in A431 cells) .

• Multifunctional Formats: Camelid single-domain antibodies (VHHs) offer advantages like deep epitope penetration and high stability , which could enhance MMP14 targeting.